Pharmaceutical giant AstraZeneca’s once a day lung cancer pill, Tagrisso, has received early FDA approval fo the treatment of patients afflicted with...
By the end of this month, AstraZeneca’s heart disease drug Brilinta is expected to hit the pharmacies. The US Food and Drug Administration has...
AstraZeneca has agreed to pay Inovio Pharmaceuticals as much as $727.5 million to secure the rights to an experimental cancer vaccine, the...
In a new study recently conducted by the British multinational pharmaceutical and biologics company AstraZeneca on their new anti-clotting drug known as...